Anil Gupta, MD
Sports Medicine · Toledo, OHNPI 1881861243
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,925 of the $13,811 with a category attached, or 64.6%. Pacira Therapeutics, Inc. accounts for 65.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $6,412 and has fallen 88.4% since, to $742 in 2025.
Across 56 payments — averaging $246.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$9K
- Stryker$2K
- Arthrex$690
- Eli Lilly$677
- Linvatec Corporation$655
- Smith+Nephew$498
- plus $597 from 13 others
What the payments were for
- Speaking & faculty fees$8,92565%
- Travel & lodging$3,46525%
- Food & beverage$1,39010%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 10 | $9,090 |
| Stryker | 5 | $1,603 |
| Arthrex | 1 | $690 |
| Eli Lilly | 1 | $677 |
| Linvatec Corporation | 1 | $655 |
| Smith+Nephew | 20 | $498 |
| Vericel Corporation | 2 | $118 |
| CDC Medical LLC | 1 | $97 |
| Rock Medical Orthopedics, Inc. | 2 | $80 |
| Pacira Pharmaceuticals Incorporated | 2 | $54 |
| Zimmer Biomet | 2 | $49 |
| Nexus Medical Technologies LLC | 1 | $44 |
| Heron Therapeutics, Inc. | 2 | $39 |
| Bioventus LLC | 1 | $25 |
| Johnson & Johnson | 1 | $24 |
| Osteomed LLC | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Medtronic | 1 | $15 |
| Convatec Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,811 in reported general payments places this provider in the 80th percentile of 278 sports medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 92 | $601 |
| Meloxicam | 29 | $127 |
| Cephalexin | 62 | $95 |
| Ibuprofen | 11 | $38 |
| Tramadol Hcl | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Toledo
- David FlaniganColumbus$915K
- Thomas EllisDublin$427K
- Paul SaluanCleveland$367K
- Vincent SammarcoCincinnati$361K
- Jovan LaskovskiAkron$337K
- Julie BishopColumbus$322K
- Dominic KingCleveland$233K
- Michael SalataCleveland$212K
- Jason GeninLorain$115K
- Christopher KaedingColumbus$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.